glp 1 prescriptions GLP-1 costs rise, but there are ways to save on weight-loss drugs Where are patients getting their

Its no longer enough to market a new weight-loss drug. Todays audiences from prescribers to patients expect a strategy that reflects clinical nuance, emotional complexity, and long-term value

The survival benefit appeared most pronounced in patients with very high BMI (over 35), hinting that GLP-1 drugs may help counteract the inflammatory and metabolic conditions that worsen colon cancer prognosis

Cercato C, Fonseca FA

As of July 1, 2026, eligible Medicare Part D beneficiaries can access three FDA-approved GLP-1 medications for chronic weight management at a flat $50 per month medication copay

doi: 10.1016/j.phrs.2022.106550 100

Tirzepatide produces 16-22.5% body weight loss over 72 weeks